These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6766694)

  • 21. Long-term parenteral nutrition and metabolic bone disease.
    Hurley DL; McMahon MM
    Endocrinol Metab Clin North Am; 1990 Mar; 19(1):113-31. PubMed ID: 2113469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aluminum loading during total parenteral nutrition.
    Klein GL; Alfrey AC; Miller NL; Sherrard DJ; Hazlet TK; Ament ME; Coburn JW
    Am J Clin Nutr; 1982 Jun; 35(6):1425-9. PubMed ID: 6805302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatitis in association with hypercalcemia in patients receiving total parenteral nutrition.
    Izsak EM; Shike M; Roulet M; Jeejeebhoy KN
    Gastroenterology; 1980 Sep; 79(3):555-8. PubMed ID: 6776004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aluminum as a factor in the bone disease of long-term parenteral nutrition.
    Klein GL; Ott SM; Alfrey AC; Sherrard DJ; Hazlet TK; Miller NL; Maloney NA; Berquist WE; Ament ME; Coburn JW
    Trans Assoc Am Physicians; 1982; 95():155-64. PubMed ID: 6820740
    [No Abstract]   [Full Text] [Related]  

  • 25. Calcium and phosphorus requirements of low birth weight infants: a nutritional and endocrinological perspective.
    Atkinson SA
    Nutr Rev; 1983 Mar; 41(3):69-78. PubMed ID: 6405330
    [No Abstract]   [Full Text] [Related]  

  • 26. Systemic inflammatory mediators and bone homeostasis in intestinal failure.
    Compher C; Pazianas M; Benedict S; Brown JC; Kinosian BP; Hise M
    JPEN J Parenter Enteral Nutr; 2007; 31(2):142-7. PubMed ID: 17308255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic bone disease in long-term total parenteral nutrition.
    DeLuca HF
    JPEN J Parenter Enteral Nutr; 1985; 9(1):71. PubMed ID: 3918208
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk of metabolic bone disease is increased both during and after weaning off parenteral nutrition in pediatric intestinal failure.
    Mutanen A; Mäkitie O; Pakarinen MP
    Horm Res Paediatr; 2013; 79(4):227-35. PubMed ID: 23636002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic bone disease in home total parenteral nutrition.
    McCullough ML; Hsu N
    J Am Diet Assoc; 1987 Jul; 87(7):915-20. PubMed ID: 3110249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?
    Ghazali A; Fardellone P; Pruna A; Atik A; Achard JM; Oprisiu R; Brazier M; Remond A; Morinière P; Garabedian M; Eastwood J; Fournier A
    Kidney Int; 1999 Jun; 55(6):2169-77. PubMed ID: 10354266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A longitudinal study of calcium regulation in a nonhuman primate model of parenteral nutrition.
    Lipkin EW
    Am J Clin Nutr; 1998 Feb; 67(2):246-54. PubMed ID: 9459372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia.
    Cuthbert JA; Pak CY; Zerwekh JE; Glass KD; Combes B
    Hepatology; 1984; 4(1):1-8. PubMed ID: 6693061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parenteral nutrition-associated metabolic bone disease.
    Seidner DL
    JPEN J Parenter Enteral Nutr; 2002; 26(5 Suppl):S37-42. PubMed ID: 12216719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D metabolites and bone mineralization in man.
    Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calciuretic effect of cyclic versus continuous total parenteral nutrition.
    Wood RJ; Bengoa JM; Sitrin MD; Rosenberg IH
    Am J Clin Nutr; 1985 Mar; 41(3):614-9. PubMed ID: 3919560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of the relationship between parenteral nutrition and metabolic bone disease.
    Ferrone M; Geraci M
    Nutr Clin Pract; 2007 Jun; 22(3):329-39. PubMed ID: 17507733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of total parenteral nutrition-induced urinary calcium loss by increasing the phosphorus in the total parenteral nutrition prescription.
    Wood RJ; Sitrin MD; Cusson GJ; Rosenberg IH
    JPEN J Parenter Enteral Nutr; 1986; 10(2):188-90. PubMed ID: 3083131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse metabolic consequences of total parenteral nutrition.
    Klein GL; Rivera D
    Cancer; 1985 Jan; 55(1 Suppl):305-8. PubMed ID: 3917364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma Aluminum Concentrations in Pediatric Patients Receiving Long-Term Parenteral Nutrition.
    Courtney-Martin G; Kosar C; Campbell A; Avitzur Y; Wales PW; Steinberg K; Harrison D; Chambers K
    JPEN J Parenter Enteral Nutr; 2015 Jul; 39(5):578-85. PubMed ID: 24743391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inorganic phosphorus reduces hypercalciuria during total parenteral nutrition by enhancing renal tubular calcium absorption.
    Berkelhammer C; Wood RJ; Sitrin MD
    JPEN J Parenter Enteral Nutr; 1998; 22(3):142-6. PubMed ID: 9586791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.